Reuters
http://www.reuters.com/
Accessed 17 November 2012

Novartis receives positive CHMP opinion for Bexsero(R), a groundbreaking vaccine to help prevent devastating MenB infections, the leading cause of meningitis in Europe
http://www.reuters.com/article/2012/11/16/idUS113890+16-Nov-2012+HUG20121116